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Abstract
Resveratrol in high doses has been shown to extend lifespan in some studies in invertebrates and to prevent early mortality
in mice fed a high-fat diet. We fed mice from middle age (14-months) to old age (30-months) either a control diet, a low
dose of resveratrol (4.9 mg kg
21 day
21), or a calorie restricted (CR) diet and examined genome-wide transcriptional profiles.
We report a striking transcriptional overlap of CR and resveratrol in heart, skeletal muscle and brain. Both dietary
interventions inhibit gene expression profiles associated with cardiac and skeletal muscle aging, and prevent age-related
cardiac dysfunction. Dietary resveratrol also mimics the effects of CR in insulin mediated glucose uptake in muscle. Gene
expression profiling suggests that both CR and resveratrol may retard some aspects of aging through alterations in
chromatin structure and transcription. Resveratrol, at doses that can be readily achieved in humans, fulfills the definition of a
dietary compound that mimics some aspects of CR.
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Introduction
Caloric restriction (CR) retards several aspects of the aging
process in mammals, including age-related mortality, tumorigen-
esis, physiological decline [1] and the establishment of age-related
transcriptional profiles [2]. The wide scope of these actions, and
the profound metabolic and hormonal shifts induced by CR has
led to efforts at identifying natural or synthetic compounds that
mimic the effects of CR in the absence of overt metabolic and
endocrine disturbances or reduced caloric intake. Because most
age-related diseases are likely to be secondary to the aging process
itself, the discovery of such compounds could have a profound
public health impact by reducing disease incidence and possibly
extending the quality and length of the human lifespan.
Resveratrol, a natural compound found in grapes and red wine
has previously been shown to extend lifespan in S. cerevisiae, C.
elegans and Drosophila through a SIRT1 dependent mechanism
[3,4]. However, recent studies have failed to reproduce these life
extension results [5,6], and other studies have demonstrated that
the ability of resveratrol to activate yeast Sir2 or human SIRT1 is
substrate-specific in vitro [7] and resveratrol has no effect on Sir2
activity in vivo [5]. Thus, the effects and mechanisms of resveratrol
in life extension in invertebrates are currently unclear. Recently,
mice fed a high fat diet supplemented with high levels of
resveratrol (22 or 186 mg kg
21 day
21) were shown to have
extended lifespan as compared to controls, and several metabolic
alterations similar to what is observed with CR, including markers
of increased mitochondrial biogenesis [8,9]. Because control
animals in this study had early mortality due to toxicity of the
high fat diet, the role of resveratrol in the aging process in
mammals is also unclear and a detailed examination of the
physiological impact of resveratrol on aging and health parameters
is indicated.
Global gene expression profiling can be used to evaluate the
biological age of a tissue, because as shown for animals subjected
to CR, such profiles correlate with biological as opposed to
chronological age [2]. Given that compounds that retard aging
may do so in a tissue-specific manner, we and others have used
PLoS ONE | www.plosone.org 1 June 2008 | Volume 3 | Issue 6 | e2264gene expression profiling as a method to search for compounds
that can mimic the effects of CR [10,11]. This study aimed to
examine the role of resveratrol in gene expression profiles
associated with mammalian aging and the specific effects of both
resveratrol and CR on gene expression patterns in multiple tissues.
We also compared the effects of resveratrol and CR in insulin
signaling, oxidative damage, age-related cardiac function, and
spontaneous tumorigenesis.
Results
Global impact of CR and resveratrol on age-related
changes in gene expression
We fed individually-housed male (C57BL/66C3H/He)F1
hybrid mice one of three diet formulations: a control diet (84
kcal mouse
21 week
21), a CR diet (63 kcal mouse
21 week
21) and
a control diet supplemented with trans-resveratrol (4.9 mg kg
21
day
21) starting at middle age (14 months of age). We have
previously reported that this CR regimen started at middle age in
this strain leads to a 13% increase in average and maximum
lifespan [10]. As expected, long-term feeding of the CR diet
resulted in a significant reduction in body weight (for control
mice, average body weight 35 g; for CR mice average body
weight 24 g; P,0.01, Supplemental Figure S1); this reduction in
body weight was not observed in resveratrol-fed animals
(Supplemental Figure S1). Mice were sacrificed at 30–31 months
of age and tissues collected for gene expression analysis. We
focused our analysis on three tissues: heart, skeletal muscle and
brain (neocortex).
To examine the age-associated changes in gene expression we
compared transcriptional profiles of young and old mice fed the
control diet. There were 1,029 genes (P#0.01) that were
significantly changed in expression with age in the heart. We
next examined the impact of CR on the expression of these genes
by comparing 30-month old CR mice and 30-month old control
mice. Age-related changes in gene expression that are prevented
by CR would be expected to show opposite directions of change
(upregulation vs. downregulation). As previously reported [2], we
observed a large effect of CR in opposing age-related changes: CR
reduced 921 (90%) age-related alterations in gene expression and
536 of these represented highly significant differences (P#0.01) in
expression between the old control and old CR groups (Figure 1A).
To examine the effect of resveratrol supplementation on age-
related gene expression patterns, we performed a similar analysis
comparing 30-month old control mice and 30-month old
resveratrol fed animals (Figure 1A). Surprisingly, resveratrol
opposed 947 (92%) of age-related changes in gene expression,
and 522 of these represented highly significant differences in
expression between the old control and old resveratrol groups
(P#0.01). Thus, resveratrol at doses that can be readily achieved
through dietary supplementation in humans is as effective as CR
in opposing the majority of age-related transcriptional alterations
in the aging heart. Because the collection of such alterations in
gene expression is a biomarker of aging, our results imply that
similar to CR, middle-age onset resveratrol supplementation at
low doses is likely a robust intervention in the retardation of
cardiac aging. Lesser effects on aging inhibition by CR and
resveratrol were obtained in skeletal muscle; aging resulted in
alteration of expression of 515 skeletal muscle genes, 136 (26%) of
which were significantly (P#0.01) opposed by CR and resveratrol
(Figure 1A). In neocortex, CR and resveratrol significantly
inhibited only 19 and 13% respectively of the 505 highly
significant age-related changes in gene expression (Figure 1A).
CR and resveratrol have overlapping effects on
alterations in gene expression in multiple tissues
We next examined the transcriptional profiles of CR and
resveratrol fed mice for genes that are impacted by the dietary
interventions, but are not altered in expression with aging. Such
changes in gene expression represent shifts induced by the dietary
interventions and can provide clues to mechanisms of action and
the degree and nature of CR mimicry by resveratrol. We identified
747 genes that were significantly altered in expression by both CR
and resveratrol in the heart (P#0.01) but were not altered in
expression as a result of normal aging. Strikingly, 745 (99.7%) of
these gene expression alterations occurred in the same direction
for both treatments (Figure 1B). This finding was also observed in
muscle (1164/1164 genes, Figure 1B) and brain (1129/1134 genes,
Figure 1B). Clearly, resveratrol can mimic a large component of
the transcriptional profile of CR in all tissues examined.
Resveratrol and CR prevent age-related cardiac
dysfunction
Cardiac function is known to decline with age in mice and
humans, a factor that likely contributes to the fact that cardiac
disease is one of the leading contributors to age-related disability
and death. To assess left ventricular (LV) systolic and diastolic
function as well as structure, we used in vivo M-mode and Doppler
echocardiography to examine cardiac function in young (five
month-old) control mice and 25 month-old control, CR and
resveratrol fed mice. Isovolumic relaxation time, a measure of
diastolic function, was increased in aged animals (Figure 2A),
consistent with the impaired LV relaxation that occurs with
normal aging in rodents and humans [12]. Both CR and
resveratrol supplementation reduced the age-related increase in
this parameter, though these changes were not statistically
significant. We also examined the myocardial performance index,
a parameter that provides an overall assessment of cardiac
function [13]. An increased index value is associated with reduced
cardiac performance, and this value increased significantly with
age (Figure 2A). Both CR and resveratrol supplementation almost
completely prevented the age-related decrease in this parameter.
Thus, resveratrol mimics the effects of CR to prevent cardiac
aging at both the transcriptional and functional levels.
Effects of resveratrol and CR on endocrine status and
glucose metabolism
In an attempt to uncover the mechanisms of action of
resveratrol in retarding aging parameters and its ability to mimic
CR, we examined pathways implicated in aging and CR. In
mammals, spontaneous mutations that result in growth hormone
(GH) deficiency, such as the Prop-1 and Pit-1 dwarf mice [14,15],
or targeted mutations in the insulin-like growth factor 1 (IGF-1)
receptor gene [16] or the insulin receptor substrate 1 (IRS1) can
result in increased lifespan [17], suggesting an important role for
IGF-1 in longevity. Some of the phenotypes that are observed in
animals with altered IGF-1 or insulin signaling are also observed in
CR mice, such as reduced levels of IGF-1, insulin and glucose
[18]. To investigate if resveratrol inhibits transcriptional profiles of
aging and mimics CR through an endocrine mechanism, we
measured glucose, T3, insulin, IGF-1 and GH in five month-old
control, CR and resveratrol fed mice. Following two months of
dietary intervention, we observed reduced IGF-1 levels in CR
mice, but not in resveratrol treated mice (Figure 2B). We did not
observe significant alterations in any other hormones examined.
Surprisingly, because we observed a large overlap of transcrip-
tional shifts induced by resveratrol and CR in all organs examined,
Resveratrol as a CR Mimetic
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transcriptional program induced by CR may be independent of
CR-mediated alterations in plasma IGF-1, or insulin. This
conclusion is supported by the finding that dwarfism and CR
may impact lifespan through independent mechanisms [19], and
the finding that GH deficiency and CR display minimal overlap at
the gene expression level [20].
Genetic alteration of insulin related pathways has clearly been
implicated in aging retardation in multiple organisms, and earlier
studies have demonstrated that mice consuming a CR diet [21] or
supplemented with resveratrol have improved insulin sensitivity
[8,9]. Both CR and resveratrol supplementation lowered blood
glucose levels (P=0.06 for CR, P=0.07 for resveratrol; Figure 2B).
Neither diet lowered plasma insulin (data not shown). We next
Figure 1. Global effects of resveratrol and CR on gene expression. Gene expression profiling of 20,687 unique transcripts using Affymetrix
Mouse Genome 430 2.0 arrays was performed in young (5-months old) control and old control, CR and resveratrol fed animals (30-months old, all
groups). (A). A panel of genes corresponding to significant (P#0.01) changes in gene expression in the comparison between young and old control
groups was examined in both CR (left) and resveratrol fed mice (right). Numbers on X and Y axes represent fold changes in the young vs. old
comparison (X axis), and the old CR vs old control (Y axis, left graphs) or old resveratrol vs. old control group (Y axis, right graphs). Each dot
corresponds to an specific gene. Red dots correspond to genes that are significantly altered in expression at P#0.01 in both aging and CR, or aging
and resveratrol comparisons. Opposite fold changes in this analysis represent prevention of aging changes. (B). A panel of genes significantly
changed by CR and resveratrol (but not by age) as compared to old control mice (P#0.01) is plotted. Similar fold changes in this analysis represent
resveratrol mimicry of CR. Pie charts represent the proportion of genes changed by CR only, resveratrol only or both treatments. Gene expression
changes plotted in graphs correspond to the genes changed significantly expression by both treatments (red).
doi:10.1371/journal.pone.0002264.g001
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extensor digitorum longus (EDL) muscles from mice fed CR or
resveratrol diets from three to five months of age. CR resulted in a
significant increase in 2-DG uptake in the insulin-stimulated soleus
(35%) and EDL (32%) muscles, without any effect on 2-DG uptake
in the basal condition. There was also an increase in 2-DG uptake
in the insulin-stimulated soleus (18%), but not in the EDL, of
resveratrol treated mice. Akt phosphorylation, which partially
mediates enhanced insulin sensitivity of muscle [22], was increased
with CR but not with resveratrol supplementation (Figure 2C).
Levels of GLUT4, the major glucose transporter in muscle, were
also increased in CR, but not resveratrol-treated mice (Figure 2B).
These findings suggest that the mechanism of the increased
glucose uptake in insulin-stimulated skeletal muscle in resveratrol
treated mice is different from that of CR mice, as neither Akt
phosphorylation nor GLUT4 content were elevated by resveratrol.
Figure 2. Effects of CR and resveratrol on physiological parameters. (A) Cardiac function as determined by transthoracic echocardiography
(n=7, YC, n=10 OC, n=8 CR, n=9 Resv) (B) Serum glucose and plasma IGF-1 in control, CR and resveratrol treated mice (C) Glucose uptake and
insulin signaling in control, CR and resveratrol fed animals (n=16). Rate of 2-deoxyglucose uptake and Akt threonine
308 (T
308) phosphorylation were
determined in isolated paired soleus and extensor digitorum longus (EDL) muscles with or without 0.36 nM insulin. Data were analyzed by two-way
ANOVA, and the source of significant variance was tested using Student-Newman-Keuls post-hoc test (n=15–16 muscles per group). There were no
differences between groups at baseline so values shown reflect insulin-stimulated values only. GLUT4 protein abundance was determined in soleus
and EDL muscles by western blotting (n=16 muscles per group). Data were analyzed by one-way ANOVA on ranks, and the source of significant
variance was tested using Dunn’s post-hoc test.
doi:10.1371/journal.pone.0002264.g002
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not resveratrol induces PGC-1a transcriptional targets
Feeding high levels of resveratrol to mice has been shown to be
associated with increased SIRT1 activity as measured by PGC-1a
acetylation and induction of its transcriptional targets [8,9].
Because sirtuin overexpression increases longevity in some
organisms and may mediate some of the effects of CR [3,4], the
induction of SIRT1 activity has been postulated to mediate the
health benefits of resveratrol [8,9]. We investigated if alterations in
the levels of SIRT1 or induction of PGC-1a transcriptional
activity can explain the observation that a low dose of resveratrol
mimics CR. In contrast to previous finding in rats [23] and
humans [24], neither CR nor resveratrol feeding significantly
altered the levels of SIRT1 protein in brain or liver of mice, and
SIRT1 abundance was actually significantly decreased in both
heart and muscle of CR mice (Figure 3A). However, CR clearly
increased the mRNA levels of Pgc-1a in skeletal muscle. CR also
stimulated an increase in Pgc-1a transcriptional targets Pdk4 and
Ucp3 in heart and skeletal muscle. In contrast, resveratrol did not
significantly increase the levels of Pgc-1a expression or any of its
transcriptional targets, with the exception of a small effect on the
expression of Pdk4 in skeletal muscle (Figure 3B). Thus, our
microarray results suggest that a low dose of dietary resveratrol
induces a transcriptional program similar to CR in multiple tissues
and retards aging parameters, but these effects may be largely
independent of the increase in SIRT1 activity and activation of
Pgc-1a transcriptional targets reported previously for mice in a
high fat diet fed high levels of resveratrol [8,9].
Effects of CR and resveratrol feeding on oxidative stress
parameters
Because resveratrol has been shown to act as an antioxidant
both in vitro and in vivo, we tested the hypothesis that resveratrol
supplementation retards aging through a reduction in oxidative
damage which has been postulated to be causal in both aging and
a number of age-related diseases. To test if resveratrol has an
impact on spontaneous oxidative damage, we measured F2-
isoprostanes, a marker of lipid peroxidation in heart, skeletal
muscle and brain of mice fed CR or resveratrol diets from three to
five months of age (Supplemental Figure 2). Surprisingly, we found
that resveratrol significantly raised the levels of F2-isoprostanes in
the heart relative to controls (P,0.05) and isoprostane levels in the
brain were higher in resveratrol treated mice compared CR mice
(P,0.01); isoprostane levels were similar among groups in muscle.
We next examined oxidative damage to DNA and RNA in the
same mice; levels of 8-hydroxy-29-deoxyguanosine (8-OHdG) and
8-hydroxyguanosine (8-OHG) were similar among groups for each
tissue (Supplemental Figure S2). Thus, our observations do not
indicate lowering of spontaneous levels of oxidative damage by
either CR or resveratrol.
Functional analysis of CR and resveratrol-mediated gene
expression changes in multiple tissues
Because resveratrol did not impact well-known factors that are
postulated to impact aging (IGF-1, insulin, Sirt1, oxidative stress),
we analyzed the gene expression data for functional categories that
may be affected with age, CR or resveratrol. We used the
significance analysis of function and expression (SAFE), a two-
stage, permutation-based method that can be applied to various
experimental designs, accounts for the unknown correlation
among genes and enables permutation-based estimation of error
rates [25]. We used the Gene Ontology (GO) Biological Process
classification scheme for annotating gene function and only
included GO terms that were represented by least 10 genes. This
resulted in 571 GO terms represented in each tissue (Supplemental
Table S1). Because our global analysis of age-independent shifts in
gene expression indicated that resveratrol mimics CR in all tissues
examined, we were particularly interested in functional classes that
were significantly altered by both interventions across tissues. Only
four GO terms were impacted by both CR and resveratrol across
all tissues (Figure 4), and these were chromatin assembly or
disassembly (GO:0006333), regulation of transcription from RNA
Polymerase II promoter (GO:0006357), transcription from RNA
polymerse II promoter (GO:0006366), and ubiquitin cycle
(GO:0006512). Analysis of individual genes within these classes
suggests that both CR and resveratrol have a major impact on
expression of genes that play important roles in chromatin
remodeling that defines the transcriptional/epigenetic state of
the cell. In skeletal muscle (Figure 5), these include the de novo
methylase Dnmt3a, the chromodomain helicase DNA binding
protein 1 (Chd1), the sirtuin Sirt5, and the SWI/SNF complex
members Smarcc1, Smarca4, Smarca5 and Smarca2. The
Smarca2 gene encodes Brahma, the key component of the
SWI/SNF complex, a master transcriptional switch that directs
specific cellular programs and uses ATP hydrolysis to remodel
chromatin [26]. Additionally, multiple histone encoding genes
were altered in expression by both CR and resveratrol. Alteration
in expression of the same or related genes was also observed in
heart and brain.
Discussion
The importance of chromatin remodeling proteins in defining
the chromatin state of the cell, basal transcription and their ability
to influence DNA repair [27] suggests a common mechanism of
action for CR and resveratrol. Based on the functional analysis of
gene expression profiles in multiple tissues we postulate that both
CR and resveratrol impact pathways that determine chromatin
remodeling, perhaps in response to a metabolic stress signal. The
ensuing alteration in chromosome architecture and transcription
may facilitate pathways that maintain genomic stability, or prevent
epigenetic alterations, and therefore retard some aspects of the
aging process in the long-term. Understanding the pathways that
influence the expression of genes involved in chromatin remod-
eling and transcription in response to both CR and resveratrol
may therefore provide key insights into the molecular basis of
aging in mammals.
Our studies suggest that dietary consumption of a low dose of
resveratrol partially mimics CR and inhibits some aspects of the
aging process. In long lived rodent strains and in humans, lifespan
is often limited by spontaneous tumorigenesis. Studies have
determined that the ability of CR to inhibit spontaneous
tumorigenesis is linked to the CR-mediated reduction in
circulating IGF-1 [28], and in the case of mammary carcinogen-
esis can be reversed by the administration of IGF-1 to CR animals
[29]. Our study design involved the use of a long-lived F1 hybrid
mouse strain, and sacrificing mice at 30-months of age, therefore
we were unable to evaluate effects of resveratrol on average or
maximum lifespan. We note that unlike CR, resveratrol did not
reduce circulating IGF-1 levels (Figure 2B), and there was also no
decrease in spontaneous tumors at the time of sacrifice
(Supplemental Table S2). In particular, spontaneous liver tumors
were abundant in mice fed the control diet or resveratrol, but rare
in CR mice. Thus, although a low dose of resveratrol can improve
quality of life by retarding aging parameters such as cardiac
dysfunction, a nutritional or pharmaceutical strategy to also
Resveratrol as a CR Mimetic
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axis or its targets.
Our study also raises questions regarding proposed mechanisms
of action of both CR and resveratrol. Findings from previous
studies performed with higher doses of resveratrol in mice
suggested that an increase in SIRT1 activity and the resulting
deacetylation of the transcriptional coactivator Pgc-1a is a central
mechanism of action. Health benefits observed included reduced
mortality associated with the high-fat diet, improved motor
performance and improved insulin sensitivity [8,9]. Surprisingly,
Figure 3. SIRT1 levels and Pgc1-a transcriptional activity in response to CR and resveratrol. (A) SIRT1 levels in liver, skeletal muscle and
brain (n=at least four animals per group) were determined by Western blot analysis. A loading correction factor based on HSP70 band intensity data
was used to normalize the SIRT1 band intensity data. (B) mRNA abundance for known Pgc-1a transcriptional targets is shown for heart, muscle and
brain. Data on Y axis represent percentage changes relative to young controls. Results represent n=5, values in bar graphs are means and SE.
* p,0.01.
doi:10.1371/journal.pone.0002264.g003
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skeletal muscle but not heart [9]. Given that resveratrol is known
to be cardioprotective in models of ischemia-reperfusion [30], and
our own findings of strong activity in the retardation of cardiac
aging, but no effects on Pgc-1a transcriptional targets, it seems
unlikely that SIRT1/Pgc-1a play a role in resveratrol’s cardiac
effects. It is likely that the effects of resveratrol feeding at lower
doses reported here are distinct than those observed with higher
doses, with particular relevance to the induction of SIRT1 activity.
We also did not find support for the hypothesis that induction of
SIRT1 directly mediates the effects of CR in the tissues examined,
since SIRT1 levels were not altered at the mRNA or protein levels.
Previous studies in rats [23] and humans [24] suggest that CR
induces SIRT1 in these species, but the only study in mice that
addressed this issue used an ‘‘every other day’’ feeding protocol,
and therefore does not represent CR [31]. To our knowledge our
study is the first to attempt to detect an induction of SIRT1 in CR
mice, and we have not observed such induction in any of the
tissues examined (heart, liver, skeletal muscle and brain). Given
that overexpression of SIRT1 in mice does induce physiological
alterations consistent with CR [32], it is possible that CR impacts
the levels of SIRT1 and other sirtuins in other tissues that play a
central role in regulating metabolism, such the pancreas [33,34].
We also note that despite the absence of SIRT1 induction, our
findings are consistent with a general alteration in the expression
of genes involved in chromatin remodeling by CR and resveratrol,
including other sirtuins (Figure 5). Other proposed biochemical
mechanisms of action of resveratrol that were not examined in this
study may include stimulation of AMP kinase [35], and increased
nitric oxide synthase activity [36–38]. We also note that studies
suggest that the nutrient sensor target of rapamycin (TOR)
pathway, involved in the regulation of growth and autophagy
mediates the life-extension effects of CR in Drosophila [39] and C.
elegans [40], and therefore may play a role in the resveratrol effects
reported here. Because resveratrol mimics CR at the gene
expression level, but did not mimic the effects of CR on the few
proteins examined in this study (GLUT4, AKT, IGF-1 and
SIRT1) it is possible that although similar at the transcriptional
level, CR and resveratrol have different effects with regard to
translational regulation. An examination of several proteins
encoded by genes affected in expression by both CR and
resveratrol should clarify this issue.
Our findings that a low dose of resveratrol partially mimics CR
at the gene expression level and leads to prevention of some age-
related parameters suggests that clinical trials with resveratrol
should be conducted to test the relevance of these findings to
humans. Because cardiac disease is a major contributor to age-
related mortality, positive findings could lead to a novel and
important approach to improve the quality of human life.
Materials and Methods
Animals and diets
Male C57BL/66C3H/He F1 hybrid mice were purchased at
six weeks of age (Harlan-Teklad), individually housed in a specific
pathogen free facility and fed a control diet based on the AIN-93M
formulation (Bio-Serv, Frenchtown, NJ). Upon arrival and until
14 months of age, mice received 84 kcal per week, approximately
10% lower than ad lib intake. Starting at 14 months of age, mice
were randomly divided into one of three groups: a Control group
receiving the same diet; a resveratrol-treated group receiving the
same diet as the controls but supplemented with 50 mg resveratrol
per kg diet (resveratrol purchased from Sigma Chemical, St.
Louis); this dose is approximately equal to 4.9 mg resveratrol per
kg body weight assuming a 35 g mouse; a calorie restricted (CR)
group receiving 63 kcal per week. Details on feeding Control and
CR diets have been published elsewhere [41]. At 30 months of
age, tissues were collected from mice, flash-frozen in liquid
nitrogen and stored at 280uC. Tissues were also collected from a
group of young control mice that received the control diet from
two to five months of age. The number of spontaneous deaths in
each cohort prior to the age of sacrifice was 2/30, 0/18 and 2/22
in the control, CR and resveratrol-treated groups, respectively
(Supplemental Table S2). Studies in young mice were performed
as described above except the CR or resveratrol treatments were
begun at two months of age and were continued through five
months of age. All procedures complied with the Institutional
Animal Care and Use Committee of the William S. Middleton
Memorial Veterans Hospital, Madison, WI
Figure 4. Functional gene expression analysis of CR and
resveratrol fed mice using SAFE. A class matrix, which describes
the functional categories and specifies what genes are members of
what classes, was based on Gene Ontology (GO), and included classes
with at least 10 genes, for a total of 571 classes. The SAFE analysis was
then run using the default settings for the local statistic (Student’s t)
and GO terms that differed at P#0.05 were considered significantly
different. Only classes that show a significant effect for at least one
treatment in one tissue are shown. Significance values for all functional
classes are shown in Supplemental Table S1. Classes highlighted in blue
were changed by both CR and resveratrol in all tissues examined.
doi:10.1371/journal.pone.0002264.g004
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Gene expression profiling was performed using Affymetrix
Mouse Genome 430 2.0 arrays as described previously [2]. Aging
comparisons were made between Young and Old Control groups;
CR and resveratrol effects were determined by comparing treated
mice to the Old Control group. Genes were considered to be
significantly different at P#0.01 using Student’s t-tests.
To discover gene classes that are significantly different between
the two groups in each comparison, we used the Significance
Analysis of Function and Expression (SAFE) analysis [25]. This
approach is a two-stage, permutation-based method that can be
applied to various experimental designs, accounts for the unknown
correlation among genes and enables permutation-based estima-
tion of error rates. The SAFE analysis requires three input data
structures: the gene expression data, a response vector, and a class
matrix. The first two were created from the array data using
custom source code to reformat the data to conform to what SAFE
expects. The class matrix, which describes the functional
categories and specifies what genes are members of what classes,
was created in a similar way and was based on Gene Ontology
(GO), and included classes with at least 10 genes. This resulted in
571 classes. The SAFE analysis was then run using the default
settings for the local statistic (Student’s t) and GO terms that
differed at P#0.05 were considered significantly different.
Cardiac function
Transthoracic echocardiography was performed using an
Acuson Sequoia (Siemens) ultrasonograph with a 15-MHz
transducer. For acquisition of two-dimensional guided M-mode
images at the tips of papillary muscles and Doppler studies, mice
were sedated by IP administration of 100 mg/kg ketamine and
maintained on a heated platform in a left lateral decubitus
position. The chest was shaved and prewarmed coupling gel
applied. Transmitral velocities were measured using Doppler pulse
Figure 5. Selected genes in skeletal muscle associated with GO:0006333 (chromatin assembly and disassembly). Means identified with
{ were significantly different from age-matched controls at p,0.05; means identified with * were significantly different from age-matched controls at
p,0.01.
doi:10.1371/journal.pone.0002264.g005
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Echocardiograms were performed and analyzed by an investigator
blinded to the experimental groups.
End diastolic and systolic left ventricular (LV) diameter as well
as anterior and posterior wall (AW and PW respectively)
thicknesses were measured on line from M-mode images using
the leading edge-to-leading edge convention. All parameters were
measured over at least three consecutive cardiac cycles and
averaged. Left ventricular fractional shortening was calculated as
[(LV diameterdiastole –LV diametersystole )/LV diameterdiastole] 6
100 and LV mass was calculated by using the formula. Relative
wall thickness was calculated as 26 Posterior walldiastole/LV
diameterdiastole. Heart rate was determined from at least three
consecutive intervals from the pulse wave Doppler tracings of the
LV outflow tract. Isovolumic relaxation time was measured as the
time from the closing of the aortic value to the opening of the
mitral value from pulse wave Doppler tracings of the LV outflow
tract and mitral inflow region. Myocardial Performance Index
(MPI) was calculated as (a-b)/b where a=mitral valve closure time
and b=aortic injection time
Glucose uptake and insulin signaling
Rate of 2-deoxyglucose uptake and Akt threonine
308 (T
308)
phosphorylation were determined in isolated paired soleus and
extensor digitorum longus (EDL) muscles at baseline with or
without 0.36 nM insulin. Data were analyzed by two-Way
ANOVA, and the source of significant variance was tested using
Student-Newman-Keuls post-hoc test (n=15–16 muscles per
group). There were no differences between groups at without
insulin so values shown reflect insulin-stimulated values only.
GLUT4 protein abundance was determined in soleus and EDL
muscles by western blotting (n=16 muscles per group). Data were
analyzed by one-way ANOVA on ranks, and the source of
significant variance was tested using Dunn’s post-hoc test.
SIRT1 abundance
Samples for western blotting were electrophoresed in polyacryl-
amide tris-acetate gels (Invitrogen) and transferred to nitrocellu-
lose. Membranes were blocked in 0.5% gelatin in TBS-T for one
hour. Primary and secondary antibodies were diluted in 0.5%
gelatin in TBS-T. Rabbit anti-SIRT1 was purchased from Upstate
(Charlottesville, VA), goat anti-HSP70 and horseradish peroxidase
(HRP)-linked donkey anti-goat IgG were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). HRP-linked goat anti-
rabbit IgG was purchased from Pierce (Rockford, IL). Chemilu-
minescent bands were visualized and analyzed using a UVP
Bioimaging Systems (Upland, CA) EpiChemi II and LabWorks
Image Acquisition and Analysis Software. HSP70 was used as a
loading control. A loading correction factor based on the HSP70
band intensity data was used to adjust the SIRT1 band intensity
data.
Isoprostanes/nucleic acid damage
Isoprostanes were quantified in skeletal muscle tissue utilizing a
highly precise and accurate method employing stable isotope
dilution mass spectrometry as described previously [42].
RNA and DNA were simultaneously isolated from tissues by
homogenization in 3M guanidine isothiocyanate (GTC) followed
by a phenol-chloroform extraction procedure with inclusion of the
metal chelator desferoxamine. Samples were hydrolyzed using
nuclease P1 and alkaline phosphatase into single nucleosides and
analyzed using a highly sensitive HPLC/EC/UV system (Cou-
lochem III, ESA Inc., Chelmsford, MA). Samples were compared
against a calibration curve with known standards to quantify the
levels of the oxidative products 8-hydroxy-29-guanosine/10
6 29-




Table S1 Complete list of Gene Ontology Biological Processes
from the SAFE analysis
Found at: doi:10.1371/journal.pone.0002264.s001 (0.11 MB
PDF)
Table S2 Necropsy results from old mice fed a control, CR or
resveratrol-supplemented diet
Found at: doi:10.1371/journal.pone.0002264.s002 (0.04 MB
PDF)
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